Abstract
Infection triggers expansion and effector differentiation of T cells specific for microbial antigens in association with metabolic reprograming. Here, we show that the glycolytic enzyme lactate dehydrogenase A (LDHA) is induced in CD8+ T effector cells via phosphoinositide 3-kinase (PI3K) signaling. In turn, ablation of LDHA inhibits PI3K-dependent phosphorylation of Akt and its transcription factor target Foxo1, causing defective antimicrobial immunity. LDHA deficiency cripples cellular redox control and diminishes ATP production in effector T cells, resulting in attenuated PI3K signaling. Thus, nutrient metabolism and growth factor signaling are highly integrated processes with glycolytic ATP serving as a rheostat to gauge PI3K-Akt-Foxo1 signaling in T cell immunity control. Such a bioenergetic mechanism for the signaling regulation may explain the century-old phenomenon known as the Warburg effect.
One-Sentence Summary:
A PI3K and LDHA circuit enables T cell immunity.
In response to antigen stimulation, naïve T (Tn) cells differentiate into effector T (Teff) cells with rewired metabolic pathways (1–4). LDHA, a glycolysis enzyme that converts pyruvate to lactate, promotes Teff cytokine expression (5). However, glycolytic control of Teff responses to infection has yet to be defined, with a recent study questing its importance (6). To this end, we infected mice with Listeria monocytogenes expressing chicken ovalbumin protein as an antigen (LM-OVA) (7). H-2Kb-OVA+ Teff cells expressed approximate five-fold higher LDHA than CD8+ Tn cells (Fig. 1A and fig. S1). Activation of Tn cells with increasing doses of anti-CD3 progressively induced LDHA expression (Fig. 1B, fig. S2A and B), in line with induction of the LDHA transcriptional regulator c-Myc (Fig. 1B and fig. S2B) (8). Notably, although proximal T cell receptor (TCR) signaling, marked by phospho-Zap70 and phospho-LAT, was saturated at low concentration of anti-CD3 (fig. S2C), PI3K-dependent Akt phosphorylation showed a response curve similar to c-Myc and LDHA (Fig. 1B and fig. S2B). Indeed, blockade of PI3K signaling repressed c-Myc and LDHA expression (Fig. 1C and fig. S2D). By contrast, phospho-Zap70 and phospho-LAT were minimally affected (fig. S2E). These observations, together with previous findings that PI3K-Akt signaling promotes expression of the glucose transporter Glut1 (9), support a multifaceted role for PI3K in control of glucose metabolism in Teff cells.
To investigate LDHA function in Teff cells, we utilized Tbx21Cre mice that targeted H-2Kb-OVA+ Teff cells (fig. S3A to C). Ldhafl/fl (designated as wild-type, WT) and Tbx21CreLdhafl/fl (designated as knock-out, KO) mice were infected with LM-OVA followed by rechallenge, as protective immunity is dependent on T cells during a recall response (7). We found that KO mice had barely detectable antigen-specific Teff cells in contrast to robust expansion in WT mice (Fig. 1D). Defective T cell responses were observed throughout the course of bacterial infection (Fig. 1E), and pathogen was efficiently cleared in WT, but not KO, mice (Fig. 1F and fig. S3D to G). Similarly diminished expansion of Teff cells was observed in KO mice infected with lymphocytic choriomeningitis virus (fig. S4A and B). Furthermore, although WT Teff cells displayed a fully activated CD44hiCD62Llo phenotype, KO Teff cells expressed high levels of CD62L (fig. S4C to F). LDHA deficiency also resulted in higher proportions of KLRG-1loCD127hi memory precursors effector cells (MPECs) at the expense of KLRG-1hiCD127lo short-lived effector cells (SLECs) (fig. S4C to F) (10). Similar dysregulation of CD62L and KLRG1 was observed in Teff cells in KO mice infected with LM-OVA (fig. S5). Notably, attenuation of glucose metabolism with 2-deoxyd-glucose affected Teff cell expansion, but not CD62L or KLRG1 expression (fig. S5), revealing a qualitatively distinct function for LDHA in control of T cell activation and differentiation.
To probe CD8+ T cell-intrinsic defects caused by LDHA deficiency, we crossed Tbx21CreLdhafl/fl mice to the OT-I TCR-transgenic background. In a co-transfer setting, time-dependent out-competition of KO OT-I T cells by WT OT-I T cells was observed in association with diminished proliferation (fig. S6A, Fig. 2A and B). Mitochondrial reactive oxygen species (ROS) has been implicated in the control of T cell proliferation (11). Although WT OT-I T cells had higher levels of total ROS, mitochondrial ROS was higher in KO OT-I T cells (fig. S6B and C). This suggested that their diminished expansion was unlikely caused by defective mitochondrial activity. In addition, KO OT-I T cells expressed lower levels of effector molecules IFN-γ, TNF-α and granzyme B (fig. S7). Furthermore, KO OT-I T cells failed to downregulate CD62L and differentiate to SLECs (Fig. 2C and fig. S8A). Thus, LDHA deficiency causes a multitude of T cell-intrinsic defects in activation, proliferation, and differentiation.
Teff cell heterogeneity is governed by growth factor signaling that modulates the transcriptional programs of T cells (12). Notably, the transcription factor Foxo1 promotes CD62L expression and MPEC generation (7, 13, 14), with its activity negatively regulated by Akt-induced phosphorylation (15, 16). Indeed, diminished phosphorylation of Akt and Foxo1 was observed in KO OT-I T cells (Fig. 2D and fig. S8B). In addition, defective phosphorylation of the mTORC1 target S6 was observed in KO OT-I T cells (fig. S8C). However, this would be unlikely to account for the severe defects of LDHA-deficient T cells, as ablation of mTORC1 causes an approximate two-fold reduction of antigen-specific T cells (17). To determine whether compromised Akt-induced Foxo1 phosphorylation might account for Teff cell defects observed in KO mice, we used a mouse strain expressing a phosphorylation-resistant form of Foxo1 (Fig. 2E and fig. S9A) (18). Compared to WT mice, Tbx21CreFoxo1AAA/+ mice had barely detectable H-2Kb-OVA+ Teff cells, which also failed to downregulate CD62L or upregulate KLRG-1 (Fig. 2F and fig. S9B to D). Thus, LDHA promotes Akt-Foxo1 signaling in CD8+ Teff cells with ectopic activation of Foxo1 recapitulating the defects associated with LDHA deficiency.
To determine whether LDHA broadly promoted Akt-Foxo1 signaling in CD8+ T cells, we crossed Ldhafl/fl mice with Cd4Cre mice to delete Ldha in Tn cells (Fig. 3A). Notably, LDHA deficiency had negligible effects on Akt-Foxo1 signaling in Tn cells; yet, activated KO T cells had diminished Akt and Foxo1, but not Zap70 or LAT, phosphorylation (Fig. 3B and fig. S10A), which was recapitulated with a LDHA inhibitor in WT T cells (fig. S10B). LDHA-catalyzed pyruvate to lactate conversion defines an efficient pathwayof carbon disposal with its deficiency predicted to diminish glycolysis-associated ATP production. Indeed, phosphorylation of the cellular energy sensor AMPKα (19) was higher in KO Teff cells (Fig. 3B and fig. S10A), in association with reduced ATP levels and glucose usage (fig. S11A and B).
To investigate whether reduced ATP production in antigen-experienced KO T cells accounted for diminished Akt-Foxo1 signaling, we restored ATP with streptolysin O (SLO) (fig. S11C and D) (20). As expected, anti-CD3/CD28-induced Akt and Foxo1 phosphorylation was inhibited in the absence of LDHA, which was unaltered by the addition of ATP (Fig. 3C and fig. S11E). SLO alone inhibited Akt and Foxo1 phosphorylation; by contrast ATP supplementation together with SLO enhanced Akt-Foxo1 signaling and corrected the defects associated with LDHA deficiency (Fig. 3C and fig. S11E). As the proximal TCR signaling was unaffected (fig. S12), we examined whether the differential bioenergetic states impacted the generation of PI3K-catalized phosphatidylinositol (3,4,5)-trisphosphate (PIP3), a rate-limiting step for PDK1-mediated Akt phosphorylation (21). Indeed, KO T cells produced lower amounts of PIP3, which was unaffected by ATP supplementation (Fig. 3D). Inclusion of SLO in the absence or presence of ATP inhibited or enhanced PIP3 generation, respectively, nullifying the differences between WT and KO T cells (Fig. 3D). Similar to murine T cells, blockade of LDHA-mediated aerobic glycolysis almost completely inhibited Akt-Foxo1 signaling in antigen-experienced human T cells, which could be corrected by SLO-assisted intracellular delivery of ATP (fig. S13). These observations reveal an evolutionarily conserved ATP-sensing property of the PI3K pathway.
LDHA-catalyzed conversion of pyruvate to lactate regenerated cytosolic oxidized nicotinamide adenine dinucleotide (NAD+) to support glycolytic ATP generation (Fig. 4A). Indeed, the NAD+/NADH ratio was lower in activated KO T cells (Fig. 4B), in association with a lower extracellular acidification rate (ECAR), but a higher oxygen consumption rate (OCR) (Fig. 4C, fig. S14A and B). The mitochondrial electron transport chain (ETC)-mediated oxygen reduction promotes ATP synthesis through oxidative phosphorylation as well as glycolysis when coupled with redox shuttle systems (Fig. 4A and fig. S14C). To delineate contribution of these ETC-dependent sources of ATP to Akt-Foxo1 signaling, we utilized an ATP synthase inhibitor oligomycin and an uncoupler FCCP (Fig. 4C–D and fig. S14C). Oligomycin attenuated Akt and Foxo1 phosphorylation in WT T cells, whereas Akt-Foxo1 signaling in KO T cells was barely detectable (Fig. 4E and fig. S14D). Notably, treatment with FCCP or oligomycin plus FCCP enhanced Akt-Foxo1 signaling in WT T cells in an ETC-dependent manner, but not in KO T cells (Fig. 4E, fig. S14D and S15), in agreement with their higher spare respiratory capacity (SRC) (Fig. 4C). In contrast to activated T cells, WT and KO Tn cells exhibited comparable ECAR and OCR (fig. S16A to C), and oligomycin or FCCP inhibited Akt and Foxo1 phosphorylation (fig. S16D). Thus, Akt-Foxo1 signaling is supported by mitochondrial and glycolytic ATP in Tn and Teff cells, respectively. Furthermore, glycolytic ATP production is enabled primarily by LDHA with ETC playing a subsidiary role (fig. S17).
Antigen stimulation of CD8+ T cells induces glucose uptake to support effector functions (8, 22–25). A selective role for glycolytic ATP to fuel PI3K signaling in Teff cells can be consequent to remodeling of the mitochondrial network (26), which may spare it as an energy house for glucose anabolism including acetyl-CoA-mediated gene regulation (5). Diminished glycolytic ATP production in LDHA-deficient Teff cells impairs PI3K, but not proximal TCR signaling. Notably, Zap70 has an ATP Km around 3 μM (27), whereas PI3Kδ, the major isoform expressed in T cells, has an ATP Km around 118 μM (28), which may render PI3Kδ to function as an ATP sensor in gauging the bioenergetic state of Teff cells. As enhanced PI3K signaling is a major oncogenic event (29), future studies will uncover whether the PI3K-LDHA positive feedback circuit provides a mechanistic explanation for the Warburg effect that is observed in cancer cells (30). Such a bioenergetic mechanism for the regulation of signaling may also guide the development of effective vaccines for infectious diseases and therapeutics for cancer.
Supplementary Material
Acknowledgments:
The authors thank members of the Li laboratory and Morgan Huse for helpful discussions.
Funding:
This work was supported by the National Institutes of Health (R01 AI 102888 to M.O.L.), the Howard Hughes Medical Institute (Faculty Scholar Award to M.O.L.), and the Memorial Sloan Kettering Cancer Center Support Grant/Core Grant (P30 CA08748).
Footnotes
Competing interests: The authors declare no competing interests.
Supplementary Materials:
Materials and Methods
Figures S1–S17
Data and materials availability:
All data is available in the main text or the supplementary materials. All materials used in the research are available upon request.
References:
- 1.Wang R, Green DR, Metabolic checkpoints in activated T cells. Nat Immunol 13, 907–915 (2012). [DOI] [PubMed] [Google Scholar]
- 2.MacIver NJ, Michalek RD, Rathmell JC, Metabolic regulation of T lymphocytes. Annu Rev Immunol 31, 259–283 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Chapman NM, Boothby MR, Chi H, Metabolic coordination of T cell quiescence and activation. Nat Rev Immunol 20, 55–70 (2020). [DOI] [PubMed] [Google Scholar]
- 4.Pearce EL, Poffenberger MC, Chang CH, Jones RG, Fueling immunity: insights into metabolism and lymphocyte function. Science 342, 1242454 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Peng M et al. , Aerobic glycolysis promotes T helper 1 cell differentiation through an epigenetic mechanism. Science 354, 481–484 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Ma EH et al. , Metabolic Profiling Using Stable Isotope Tracing Reveals Distinct Patterns of Glucose Utilization by Physiologically Activated CD8+ T Cells. Immunity, (2019). [DOI] [PubMed] [Google Scholar]
- 7.Kim MV, Ouyang W, Liao W, Zhang MQ, Li MO, The transcription factor Foxo1 controls central-memory CD8+ T cell responses to infection. Immunity 39, 286–297 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Wang R et al. , The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity 35, 871–882 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Wofford JA, Wieman HL, Jacobs SR, Zhao Y, Rathmell JC, IL-7 promotes Glut1 trafficking and glucose uptake via STAT5-mediated activation of Akt to support T-cell survival. Blood 111, 2101–2111 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Joshi NS et al. , Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. Immunity 27, 281–295 (2007). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Sena LA et al. , Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling. Immunity 38, 225–236 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Kaech SM, Cui W, Transcriptional control of effector and memory CD8+ T cell differentiation. Nat Rev Immunol 12, 749–761 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Rao RR, Li Q, Gubbels Bupp MR, Shrikant PA, Transcription factor Foxo1 represses T-bet-mediated effector functions and promotes memory CD8(+) T cell differentiation. Immunity 36, 374–387 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Hess Michelini R, Doedens AL, Goldrath AW, Hedrick SM, Differentiation of CD8 memory T cells depends on Foxo1. J Exp Med 210, 1189–1200 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Ouyang W, Li MO, Foxo: in command of T lymphocyte homeostasis and tolerance. Trends Immunol 32, 26–33 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Hedrick SM, Hess Michelini R, Doedens AL, Goldrath AW, Stone EL, FOXO transcription factors throughout T cell biology. Nat Rev Immunol 12, 649–661 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Pollizzi KN et al. , mTORC1 and mTORC2 selectively regulate CD8(+) T cell differentiation. J Clin Invest 125, 2090–2108 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Ouyang W et al. , Novel Foxo1-dependent transcriptional programs control T(reg) cell function. Nature 491, 554–559 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Rolf J et al. , AMPKalpha1: a glucose sensor that controls CD8 T-cell memory. Eur J Immunol 43, 889–896 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Walev I et al. , Delivery of proteins into living cells by reversible membrane permeabilization with streptolysin-O. Proc Natl Acad Sci U S A 98, 3185–3190 (2001). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Costello PS, Gallagher M, Cantrell DA, Sustained and dynamic inositol lipid metabolism inside and outside the immunological synapse. Nat Immunol 3, 1082–1089 (2002). [DOI] [PubMed] [Google Scholar]
- 22.Cham CM, Gajewski TF, Glucose availability regulates IFN-gamma production and p70S6 kinase activation in CD8+ effector T cells. J Immunol 174, 4670–4677 (2005). [DOI] [PubMed] [Google Scholar]
- 23.Gubser PM et al. , Rapid effector function of memory CD8+ T cells requires an immediate-early glycolytic switch. Nat Immunol 14, 1064–1072 (2013). [DOI] [PubMed] [Google Scholar]
- 24.Ho PC et al. , Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses. Cell 162, 1217–1228 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Menk AV et al. , Early TCR Signaling Induces Rapid Aerobic Glycolysis Enabling Distinct Acute T Cell Effector Functions. Cell Rep 22, 1509–1521 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Buck MD et al. , Mitochondrial Dynamics Controls T Cell Fate through Metabolic Programming. Cell 166, 63–76 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Isakov N, Wange RL, Watts JD, Aebersold R, Samelson LE, Purification and characterization of human ZAP-70 protein-tyrosine kinase from a baculovirus expression system. J Biol Chem 271, 15753–15761 (1996). [DOI] [PubMed] [Google Scholar]
- 28.Somoza JR et al. , Structural, biochemical, and biophysical characterization of idelalisib binding to phosphoinositide 3-kinase delta. J Biol Chem 290, 8439–8446 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Goncalves MD, Hopkins BD, Cantley LC, Phosphatidylinositol 3-Kinase, Growth Disorders, and Cancer. N Engl J Med 379, 2052–2062 (2018). [DOI] [PubMed] [Google Scholar]
- 30.Warburg O, The Metabolism of Carcinoma Cells. The Journal of Cancer Research 9, 148–163 (1925). [Google Scholar]
- 31.Levine AG et al. , Stability and function of regulatory T cells expressing the transcription factor T-bet. Nature 546, 421–425 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
All data is available in the main text or the supplementary materials. All materials used in the research are available upon request.